Official Title
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
Brief Summary

Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and respiratory failure. Predictors for early detection and risk stratification are urgently needed. Moreover, only scarce information is available for long-term follow-up and late complications associated with infection. We therefore aimed to find predictors for severe courses of the novel disease as well as to establish strategies for therapeutic monitoring and follow-up.

Unknown status
SARS-COV2
COVID
Eligibility Criteria

Inclusion Criteria:

- SARS-CoV-2 infection / COVID 19

Exclusion Criteria:

- invasive ventilation

- respiratory failure at admission

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Germany
Locations

Thoraxklinik at Heidelberg University
Heidelberg, Germany

Investigator: Frederik Trinkmann, MD
Contact: + 49 6221 396
frederik.trinkmann@med.uni-heidelberg.de

Contacts

Frederik Trinkmann, MD
+49 6221 396 - 1201
frederik.trinkmann@med.uni-heidelberg.de

Heidelberg University
NCT Number
MeSH Terms
COVID-19